Evidence map›Paper›PMID 42899019›Full record

ReviewFrontiers in immunology2026

The emerging role of CRISPR-Cas systems in helicobacter pylori and the gut microbiota as regulators of gastrointestinal cancer risk.

Muqadas Bhatti, Husna Irfan Thalib, Ammarah Tayyebah, Aleena Zobairi, Nada Dahan, Fatma E Hassan

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Muqadas BhattiDepartment of Public Health, Bahria University, Karachi, Pakistan.
Husna Irfan ThalibGeneral Medicine Practice Program, Batterjee Medical College, Jeddah, Saudi Arabia.
Ammarah TayyebahGeneral Medicine Practice Program, Batterjee Medical College, Jeddah, Saudi Arabia.
Aleena ZobairiGeneral Medicine Practice Program, Batterjee Medical College, Jeddah, Saudi Arabia.
Nada DahanSchool of Medicine, Cardiff University, Cardiff, United Kingdom.
Fatma E HassanMedical Physiology Department, Kasr Alainy, Faculty of Medicine, Cairo University, Giza, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastrointestinal cancers contribute to 26% of global cancer incidence and 35% of deaths, with major contributors such as

Indexed as

CRISPR-Cas SystemsGastrointestinal MicrobiomeGastrointestinal NeoplasmsHelicobacter InfectionsHelicobacter pyloriAnimalsHost-Pathogen InteractionsHumansbiomarkersCRISPR-Cas systemsdysbiosisgastrointestinal neoplasmsHelicobacter pylorimicrobiotatumor

Identifiers

PMID42899019
PMCPMC13678479

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.